AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Janux Therapeutics' 15-minute chart has recently triggered a MACD Golden Cross and RSI Oversold reading, which suggests that the stock price has the potential to continue rising. The rapid decline in stock price has brought it below its fundamental support level, indicating a potential rebound in the near future.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet